Acute oral toxicity of two products from a microbial pest control agent (Beauveria bassiana) on physiological status aspects of male albino rats

Background: Synthetic pesticides have accumulated in environment causing harm to humans and ecosystems. As a result, the use of biopesticides in agriculture and public health has expanded as a substitute for traditional pesticides. Purpose: To investigate the acute oral toxicity of Beauveria bassiana, on physiological status aspects of male rats. Material and Methods: Metabolic crude (MC), and wettable powder formulation (2.5% WP) from the local isolate of B. bassiana (AUMC 9896) were tested on adult Sprague Dawley (SD) male rats by single oral dose. Results: There was no evidence of death or toxic symptoms in any of the treated groups. In contrast, each product caused a significant increase in the body weight gain and relative liver weights of B. bassiana-exposed male and reduced the brain somatic index with WP only as compared to the control. The studied bioinsecticide also caused a substantial rise in total erythrocyte and absolute differential leucocyte counts, while red blood cell distribution width (RDW) and platelet count (Plt) were decreased significantly. Furthermore, male rats exposed to both types of B. bassiana, aspartate aminotransferases (AST), total protein (TP), albumin (Alb), AST/ALT, triglyceride, and very low-density lipoprotein cholesterol (VLDL) were elevated compared to the untreated group, whereas alkaline phosphatase (ALP) activity, globulin (Glb), Alb/Glb, urea content, and low-density lipoprotein cholesterol (LDL) count fluctuated between increased and decreased. Also, B. bassiana-treated rats had lower serum cholesterol and high-density lipoprotein cholesterol levels (HDL) values.Conclusion: These results suggest that both treatments have slight effects on complete blood count (CBC) of treated male rats and marked effect on liver function, lipid profile, body weight gain and somatic index of the liver and brain

Parvovirus B19 viremia in children with systemic lupus erythematosus

Background: Parvovirus B19 infection may present with fever, rash, nonerosive arthritis, hepatitis, anemia, thrombocytopenia, leucopenia and positive ANA, B19 infection may be misdiagnosed as new onset systemic lupus erythematosus. At the same time, B19 infection and systemic lupus erythematosus may occur simultaneously in some patients. A casual relationship between B19 infection and classic idiopathic systemic lupus erythematosus has not been demonstrated yet. Objectives: This study was undertaken to investigate the seroprevalence of parvovirus B19 in SLE patients and to search for the different correlates of this viremia with positive results. Methods: This case-control study was conducted on 30 patients with SLE and 30 normal controls. All the children were subjected to detailed medical history, Clinical examination, laboratory estimation as sera from them were examined for parvovirus B19 infection by serological assays using nested polymerase chain reaction and IgG and IgM antiB19 antibodies by ELISA. Results: Parvovirus B19 DNA was detected in 11 of the 30 patients with SLE (33.3 percent) while it was not detected in any of our normal controls. Of the 11 patients with B19 DNA, only two had IgG anti-B19 antibody and one had IgM anti-B19 antibodies, whereas IgG and IgM anti-B19 antibodies were detected in 11(57.8%)and 9 (47.3%)of 19 SLE patients without B19 DNA respectively. B19 DNA was found more commonly in sera from SLE patients without anti-B19 antibodies than in those with anti-B19 antibodies (P < 0.05). Conclusions: parvovirus B19 might induce either idiopathic SLE in a person who is genetically susceptible or it might induce a SLE-like picture. Parvovirus B19 infection in patients with SLE may be due to lack of anti-B19 antibodies because of either the immunocompromised nature of the host or the use of immunosuppressive drugs. There was a higher prevalence of hypocomplementemia in patients with parvovirus B19 viremia than in those without parvovirus. Keywords: Human parvovirus B19, Systemic lupus erythematosus, Nested PCREgypt J Pediatr Allergy Immunol 2011;9(2):71-7

Evaluation of different biochemical markers in prediction of metabolic syndrome in polycystic ovary syndrome patients

Background: Polycystic ovary syndrome (PCOS) is the commonest cause of chronic hyperandrogenic anovulation. Insulin resistance and compensatory hyperinsulinemia are keys of the pathogenesis of PCOS. It is also considered as a metabolic disorder. Since the components of metabolic syndrome (MBS) namely obesity, glucose intolerance, dyslipidemia, and hypertension are the common features of this syndrome. The association between MBS and PCOS can be explained by different theories as insulin resistance, obesity, and related adipose tissue factors (adipocytokines) independent of insulin resistance are the main pathogenic contributors to both disorders.Methods: A total of 143 women with PCOS were recruited as study subjects. All participants were subjected to anthropometric measurements, clinical assessment, and biochemical tests [fasting glucose, fasting insulin, and homeostatic model assessment-insulin resistance (HOMA-IR)]. Hormonal profile particularly leptin and homocysteine levels were also evaluated.Results: 25 patients (17.4%) out of 143 women with PCOS met the criteria for MBS. Patients with MBS had significantly higher body mass index, blood pressure, HOMA-IR, leptin, and homocysteine levels compared to PCOS only patients. When HOMA-IR cut off was ≥4.3 sensitivity and specificity were 90%, 88.6%, but when leptin level was ≥34.5 the corresponding statistics were 79.6%, 75.5%.Conclusions: Serum leptin, homocysteine, HOMA-IR as well as other biochemical markers are significantly higher in women with PCOS and MBS compared to PCOS only women. PCOS is associated with various factors like insulin resistance, obesity, and dyslipidemia. Consequently, adipocytokines and HOMA-IR play important role in the prediction of MBS in patients with PCOS

Evaluation of selective peripheral neurotomies in the treatment of refractory lower limb spasticity in adults

Background: ‘‘Selective peripheral neurotomies” (SPNs) are indicated for the treatment of refractory focal and multifocal spasticity of lower limbs in adults.Objective: To evaluate the surgical results of selective peripheral neurotomies in 20 adult patients who had refractory focal & multifocal spasticity of the lower limbs, follow up period of one year.Patients and Methods: Prospective study included 20 adult patients who had refractory spasticity of the lower limbs. Preoperative evaluation for muscle tone using Modified Ashworth Score (MAS), muscle power using Medical Research Council Scale (MRCS), functional assessment using Oswestry Functional Scale (OFS) and Range Of Motion (ROM) using manual goniometry were done for all patients. All cases underwent surgery in the form of SPN of tibial, obturator, sciatic and/or femoral nerves. Follow up of the patients was done at 10th day, 3, 6 months and one year postoperatively.Results: The mean age of patients was 31.35 ± 12.42 years. There were statistically significant improvement of muscle tone, muscle power, functional assessment and range of motion between preoperative and one year postoperative values. Improvement of the muscle tone was from a preoperative Mean ± SD of 3.60 ± 0.68 on MAS to a postoperative 2.30 ± 0.86 at one year, improvement of muscle power on MRCS was from preoperative Mean ± SD 3.75 ± 1.08 to postoperative 4.08 ± 0.69 at one year, There was a functional improvement from a preoperative Mean ± SD of 3.0 ± 0.73 on OFS to 3.60 ± 0.60 at one year postoperatively. Also, there was a significant improvement between preoperative ROM Mean ± SD 61.25 ± 15.29 and one year postoperatively 72.25 ± 12.19.Conclusions: Selective peripheral neurotomies could effectively improve muscle tone, muscle power, functional performance & range of motion in patients with refractory focal and multifocal spasticity in the lower limbs.Keywords: Selective peripheral neurotomies, Spasticity, Neuroablative surgeries, Functional neurosurger

Estudio sobre el efecto de la vanillina (aditivo alimentarlo) en algunas reacciones metabólicas de animales experimentales

Vanillin (4-hydroxy-3-methoxybenzaldehyde) was administrated to hypercholesterolemic albino rats at low and high doses (1.0 and 2.0%, respectively) for nine weeks period. Lipid pattern, as well as liver and kidneys functions were determined in normal, hypercholesterolemic and hypercholesterolemic rats administrated vanillin. Hypercholesterolemia was characterized by significant increase in the average levels of total lipids, total cholesterol and triglycerides and a significant decrease in phospholipids content. Also, liver function (S.GOT, S.GPT, alkaline and acid phosphatase) as well as kidneys function were elevated compared to control group. Administration of vanillin significantly reduced liver and kidneys total lipids. Spleen and heart followed nearly the same trend but with moderate effect, while brain was not affected. Liver, kidneys, spleen and heart total cholesterol was significantly reduced while brain total cholesterol was not affected. Triglycerides were significantly decreased in liver and spleen, while that of kidneys and brain was not affected. Also, there was a significant decrease in the high activity of S.GOT, S.GPT, alkaline and acid phosphatase and the values were nearly attained to the initial level. Administration of vanillin exertes potent anabolic effects for protein metabolism as shown from the results of uric acid and creatinine.Se administró vanillina (4-hidroxi-3-metoxibenzaldehído) a ratas albino hipercolesterolémicas en dosis bajas y altas (1,0 y 2,0% respectivamente) por un período de nueve semanas. La forma lipídica así como las funciones hepáticas y renales se determinaron en ratas normales, hipercolesterolémicas e hipercolesterolémicas a las que se les administró vanillina. La hipercolesterolemia se caracterizó por un aumento significativo en los niveles medios de lípidos totales, colesterol total y triglicéridos, y una disminución significativa en el contenido de fosfolípidos. También, la función hepática (S.GOT, S.GPT, alcalina y ácido fosfatasa) así como las funciones renales se elevaron en comparación con el grupo control. La administración de vanillina redujo significativamente los lípidos totales de hígado y riñones. El bazo y corazón siguieron la misma tendencia pero con efecto moderado, mientras que el cerebro no se afectó. El colesterol total en hígado, riñones, bazo y corazón disminuyó significativamente, en tanto que en cerebro no se afectó. Los triglicéridos disminuyeron significativamente en hígado y bazo, mientras que no se alteraron en riñones y cerebro. También hubo una disminución significativa en la alta actividad de S.GOT, S.GPT, alcalina y fosfatasa acida y se alcanzaron valores muy próximos al nivel inicial. La administración de vanillina ejerció efectos anabólicos potentes para el metabolismo de proteínas como se demuestra de los resultados del ácido urónico y creatinina

Studies on the effect of vanillin (food additive) on some metabolic reactions of the experimental animals

Vanillin (4-hydroxy-3-methoxybenzaldehyde) was administrated to hypercholesterolemic albino rats at low and high doses (1.0 and 2.0%, respectively) for nine weeks period. Lipid pattern, as well as liver and kidneys functions were determined in normal, hypercholesterolemic and hypercholesterolemic rats administrated vanillin. Hypercholesterolemia was characterized by significant increase in the average levels of total lipids, total cholesterol and triglycerides and a significant decrease in phospholipids content. Also, liver function (S.GOT, S.GPT, alkaline and acid phosphatase) as well as kidneys function were elevated compared to control group. Administration of vanillin significantly reduced liver and kidneys total lipids. Spleen and heart followed nearly the same trend but with moderate effect, while brain was not affected. Liver, kidneys, spleen and heart total cholesterol was significantly reduced while brain total cholesterol was not affected. Triglycerides were significantly decreased in liver and spleen, while that of kidneys and brain was not affected. Also, there was a significant decrease in the high activity of S.GOT, S.GPT, alkaline and acid phosphatase and the values were nearly attained to the initial level. Administration of vanillin exertes potent anabolic effects for protein metabolism as shown from the results of uric acid and creatinine.Se administró vanillina (4-hidroxi-3-metoxibenzaldehído) a ratas albino hipercolesterolémicas en dosis bajas y altas (1,0 y 2,0% respectivamente) por un período de nueve semanas. La forma lipídica así como las funciones hepáticas y renales se determinaron en ratas normales, hipercolesterolémicas e hipercolesterolémicas a las que se les administró vanillina. La hipercolesterolemia se caracterizó por un aumento significativo en los niveles medios de lípidos totales, colesterol total y triglicéridos, y una disminución significativa en el contenido de fosfolípidos. También, la función hepática (S.GOT, S.GPT, alcalina y ácido fosfatasa) así como las funciones renales se elevaron en comparación con el grupo control. La administración de vanillina redujo significativamente los lípidos totales de hígado y riñones. El bazo y corazón siguieron la misma tendencia pero con efecto moderado, mientras que el cerebro no se afectó. El colesterol total en hígado, riñones, bazo y corazón disminuyó significativamente, en tanto que en cerebro no se afectó. Los triglicéridos disminuyeron significativamente en hígado y bazo, mientras que no se alteraron en riñones y cerebro. También hubo una disminución significativa en la alta actividad de S.GOT, S.GPT, alcalina y fosfatasa acida y se alcanzaron valores muy próximos al nivel inicial. La administración de vanillina ejerció efectos anabólicos potentes para el metabolismo de proteínas como se demuestra de los resultados del ácido urónico y creatinina

The Role of Humoral Innate Immunity in Hepatitis C Virus Infection

Infection with Hepatitis C Virus (HCV) causes chronic disease in approximately 80% of cases, resulting in chronic inflammation and cirrhosis. Current treatments are not completely effective, and a vaccine has yet to be developed. Spontaneous resolution of infection is associated with effective host adaptive immunity to HCV, including production of both HCV-specific T cells and neutralizing antibodies. However, the supporting role of soluble innate factors in protection against HCV is less well understood. The innate immune system provides an immediate line of defense against infections, triggering inflammation and playing a critical role in activating adaptive immunity. Innate immunity comprises both cellular and humoral components, the humoral arm consisting of pattern recognition molecules such as complement C1q, collectins and ficolins. These molecules activate the complement cascade, neutralize pathogens, and recruit antigen presenting cells. Here we review the current understanding of anti-viral components of the humoral innate immune system that play a similar role to antibodies, describing their role in immunity to HCV and their potential contribution to HCV pathogenesis